CCC Diagnostics, Inc to Present Breast Cancer Study Results at Paris Conference

Share |

CCC Diagnostics, in present data describing expanded clinical studies of the DirectHit® Panel for Breast Cancer at the 2nd Worldwide Innovative Networking (WIN) in personalized cancer medicine conference on July 7, 2010 in Paris, France.

(I-Newswire) June 10, 2010 - June 09, 2010 - CCC Diagnostics, in conjunction with Dr. Katherine Tkaczuk of the University of Maryland Greenebaum Cancer Center, will present data describing expanded clinical studies of the DirectHit® Panel for Breast Cancer at the 2nd Worldwide Innovative Networking (WIN) in personalized cancer medicine conference on July 7, 2010 in Paris, France. The data being presented at WIN will show that DirectHit can predict the responsiveness of late stage breast cancer patients to two additional classes of chemotherapy drugs, taxanes and 5-FU, with a high degree of accuracy

“The data presented at WIN supports our position that The DirectHit® Test Panel for Breast Cancer allows a new approach to drug selection” said John Hughes, President and CEO of CCC Diagnostics. “The information provided by this test supplies crucial information to aid the physician in selecting an effective drug regimen for the individual breast cancer patient.”

About CCC Diagnostics Inc:
CCC Diagnostics, Inc. was formed in 2004 by a group of scientists from the Johns Hopkins University School of Public Health, and led by the late Dr. Paul O. P. Ts’o, the former Director of the school’s Biophysics Division.
CCC Diagnostics, Inc. actively integrates discoveries in diagnostic, therapeutic and information technologies to create innovative approaches to cancer disease management and to enhance the quality of life for cancer patients. Our strategy is to provide effective, personalized chemotherapy treatment recommendations, increasing life quality and decreasing cost through appropriate drug choice.
CCC Diagnostics is located in the Caton Research Park in Baltimore, MD

Company Contact Information
CCC Diagnostics Inc
Scott Deamond
3918 Vero Rd Suite B
Baltimore MD
21227
Phone : 410-633-4885 x1071

Print Release

Share this News Release

Published in:

Science and Research

Tags:

diagnostics brast cancer biomarkers

Published on:

June 10, 2010

Content Disclaimer: If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service company and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter,make sure to check the official company website for accurate release dates as our site displays the date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.

Related Releases

Facebook Announces Tweaks on Policy Change
Facebook has announced another round of updates to previous drafts of its terms of service named Statements of Rights and Responsibilities in an attempt to ease concerns on information sharing and privacy.

Sound Mental Health Supported By The Science Of Dream Interpretation And Dream Therapy
ScientificDreamInterpretation.com is a website that tackles the scientific method of dream interpretation that is aimed at attaining good health, wisdom and happiness.

Faculty Of 1000 Launches A Revolutionary Article Search Engine: The F1000 SmartSearch
Faculty of 1000 (F1000) today announced the launch of a new intuitive PubMed search tool, the F1000 SmartSearch.

Valuable Scientific Discussions At The Third International DDI Workshop At Marbach Castle, Germany
The organisation team of the 3rd International DDI (drug-drug interactions) Workshop has expressed great satisfaction with the course of the scientific meeting. The participants of the DDI Workshop commended the high scientific level of the workshop.

International Conference and Exhibition on Biosensors & Bioelectronics
OMICS Publishing Group is an Open Access publication model that enables the dissemination of research articles to the global community. Thus, all articles published under open access can be accessed by anyone. We strongly support the Open Access.